09:40 | 20/11/2020
The elderly people are target subjects of the prevention and control of the COVID-19 pandemic. All COVID-19 vaccine developers and manufacturers need to prove the effectiveness of vaccines with the trials on this group.
15:10 | 11/11/2020
Reuters has recently published an article saying that Vietnam would continue to implement anti-COVID-19 measures as it has done instead of rushing to secure a supply of vaccine that could be financially risky.
14:39 | 11/11/2020
Germany-based biotech firm, Pfizer and BioNTech, announced that their Covid-19 vaccine showed more than 90% effective, fueling hope for successful preventing infection to human. However, it seems to have to conquer many challenges before there is widespread vaccination.
15:12 | 10/11/2020
A representative of the Russian Health Ministry said on Monday that its Sputnik V vaccine is more than 90 percent effective in COVID-19 treatment, just a few hours after the US’s Pfizer pharmaceutical company announced the effectiveness rate of its experimental vaccine is over 90 percent.
16:17 | 02/11/2020
Military Hospital 103 of the Vietnam Military Medical Academy will start the clinical trial of the Covid-19 vaccine this October, Zing reported.
11:06 | 02/11/2020
The first group of volunteers aged 60 and older has been vaccinated against the novel coronavirus with Russia’s Sputnik V vaccine, said Chief Researcher of Russia’s Central Clinical Hospital Nikita Lomakin, who heads the trials.
09:51 | 23/10/2020
Brazilian President Jair Bolsonaro on Wednesday rejected the announced purchase of 46 million doses of a potential vaccine against the coronavirus being developed by a Chinese company and tested in a state governed by a political rival, prompting some to question if he was allowing politics to steer public health decisions.
10:08 | 16/10/2020
Vietnam has ordered batches of COVID-19 vaccines from several foreign partners, including Russia and the UK, Foreign Ministry spokesperson Le Thi Thu Hang confirmed Thursday afternoon.
10:11 | 15/10/2020
EpiVacCorona has become the second COVID-19 vaccine candidate to get regulatory approval in Russia after Sputnik V. Here are some key things about the vaccine.
15:19 | 14/10/2020
The vaccine, first licensed by Russian authorities for domestic use in August, is currently being tested on 40,000 volunteers in Moscow as part of a late-stage trial known as Phase III.
13:13 | 28/09/2020
China is unlikely to reopen borders completely as the global mortality rate from Covid-19 remains high.
14:56 | 02/09/2020
U.S. says not to join WHO-linked effort for coronavirus vaccine
08:58 | 27/08/2020
Anthony Fauci cautioned Monday that rushing out a COVID-19 vaccine under special emergency use guidelines before it has been proved safe and effective could undermine the testing of other, possibly more successful, vaccines.
10:29 | 26/08/2020
Clinical trials for the Oxford coronavirus vaccine may provide enough safety and efficacy data for it to be given to regulators this year, but corners cannot be cut to speed up approval for emergency use, lead scientist of the trials said Tuesday.
16:45 | 25/08/2020
Vietnam and other Mekong countries will receive priority once China completes developing a COVID-19 vaccine, Chinese Premier Li Keqiang pledged Monday.
16:59 | 19/08/2020
According to the head of a major state-owned Chinese pharmaceutical company Sinopharm, its coronavirus vaccine may cost some hundred yuan per shot and around 1,000 yuan (USD 144.27) for two shots, which are ten times higher than that of Russian.
00:27 | 13/08/2020
Russian business conglomerate Sistema has said it expects to put the vaccine, developed by Moscow’s Gamaleya Institute, into mass production by the end of the year while experts expressing concerns and doubt.
09:14 | 12/08/2020
Several Latin American, Middle Eastern and Asian countries have expressed an interest in purchasing the Russian vaccine named Sputnik, while several contracts have been finalised, says Kirill Dmitriyev, the head of the RDIF which finances the vaccine project.
07:55 | 12/08/2020
Any WHO stamp of approval on a COVID-19 vaccine candidate would require the rigorous safety data assessment, a WHO spokesman said on Tuesday after Russia announced its “'world first” COVID-19 vaccine approved for use.
19:09 | 11/08/2020
Russia has become the first to approve a COVID-19 vaccine, developed by the Gamaleya Institute in Moscow, with production and tens of thousands of inoculations to follow, President Vladimir Putin announced Tuesday.
